A new lung detection machine at CHRISTUS St. Frances Cabrini Hospital is helping doctors identify lung issues earlier.
MethylScan is a low-cost blood test that detects multiple cancers and liver diseases by analyzing DNA methylation patterns ...
Lung cancer remains the leading cause of cancer-related deaths worldwide, accounting for nearly one in five cancer deaths – ...
Five poster presentations span lung cancer early detection, immunotherapy response prediction, cancer subtyping, treatment monitoring, and next-generation ...
A Cell Perspective argues that generative AI models could help tackle cancer’s multiscale, multimodal complexity by ...
DELFI Diagnostics to showcase whole-genome cfDNA platform advances in cancer detection and monitoring at AACR 2026 meeting: Palo Alto, California Wednesday, April 8, 2026, 15:00 H ...
Lung cancer remains the leading cause of cancer-related deaths worldwide, accounting for nearly one in five cancer deaths - around 1.8 million lives lost each year.
New cfDNA test enables multicancer detection with high accuracy, offering a cost effective approach for early diagnosis and ...
Scientists have developed a simple and cost-effective blood test that shows promise for detecting multiple cancers, various ...
MethylScan is a low-cost blood test that detects cancers and organ diseases by analyzing DNA methylation, improving early diagnosis, and identifying disease origin.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results